Results 61 to 70 of about 5,257 (166)

A Case With Recovery of Response to Tolvaptan Associated With Remission of Acute Kidney Injury and Increased Urine Osmolality

, 2013
Teruhiko Imamura, Koichiro Kinugawa, Naoko Kato, Shun Minatsuki, Hironori Muraoka, Toshiro Inaba, Hisataka Maki, Taro Shiga, Masaru Hatano, Yumiko Hosoya, Masao Takahashi, Atsushi Yao, Shunei Kyo, Minoru Ōno, Issei Komuro   +14 more
openalex   +2 more sources

Tolvaptan-Loaded Tomato-Derived Nanovesicles: Characterization and Evaluation of Cytotoxicity, Wound Healing Potential and the Effects on Cyst Formation in Renal Cell Lines. [PDF]

Int J Nanomedicine
Mammadova R, Pratiwi FW, Fiume I, Abdelrady E, Makieieva O, Zucaro L, Trepiccione F, Vainio S, Pocsfalvi G.   +8 more
europepmc   +1 more source

Tolvaptan Attenuates Left Ventricular Fibrosis After Acute Myocardial Infarction in Rats

, 2013
Takanori Yamazaki, Yasuhiro Nakamura, Masayuki Shiota, Mayuko Osada‐Oka, Hiroyuki Fujiki, Akihisa Hanatani, Kenei Shimada, Katsuyuki Miura, Minoru Yoshiyama, Hiroshi Iwao, Yasukatsu Izumi   +10 more
openalex   +2 more sources

Cirrhosis‐related hyponatremia and the role of tolvaptan [PDF]

Hepatology Research, 2015
Yoshiyuki Takei, Tomoaki Ishihara, Hiroshi Hasegawa, Motoh Iwasa   +3 more
openaire   +3 more sources

Effectiveness of Urea and Tolvaptan in the Treatment of Hypotonic Hyponatremia. [PDF]

J Clin Med
Delgado-Cuesta J, Escorial-Moya C, Vallejo-Vaz AJ, Santos-Ramos B, Varela JM, Calderón EJ, Medrano FJ.   +6 more
europepmc   +1 more source

Assessment of Quality of Life During Long-Term Treatment of Tolvaptan in Refractory Heart Failure

, 2014
Teruhiko Imamura, Koichiro Kinugawa, Tomohito Ohtani, Yasushi Sakata, Taiki Higo, Shintaro Kinugawa, Hiroyuki Tsutsui, Kenji Sunagawa, Issei Komuro   +8 more
openalex   +2 more sources

Renoprotective effects of combination therapy with tolvaptan and dapagliflozin in autosomal dominant polycystic kidney disease: a four-case series. [PDF]

CEN Case Rep
Nishida J, Yamakawa M, Miura S, Yasutomi M.   +3 more
europepmc   +1 more source

Factors necessitating tolvaptan continuation in the outpatient setting for heart failure [PDF]

, 2016
Keiichi Tsuchida, Ryohei Sakai, Kota Nishida, Jiro Hiroki, Asami Kashiwa, Norihito Nakamura, Yuki Fujihara, Yukio Hosaka, Kazuyoshi Takahashi, Hirotaka Oda   +9 more
openalex   +1 more source

Kidney Function Trajectories with Tolvaptan in ADPKD Patients with CKD-G5. [PDF]

Kidney Int Rep
Sekine A, Hoshino J, Mochizuki T, Nakatani S, Nishio S, Suwabe T, Hayashi H, Kai H, Seta K, Hattanda F, Hidaka S, Hanaoka K, Kurashige M, Kataoka H, Uchiyama K, Shimazu K, Ishikawa E, Shimada Y, Kawano H, Tsuchiya K, Horie S, Narita I, Isaka Y, Muto S.   +23 more
europepmc   +1 more source

#tolvaptan è Ancora Fermo ma noi NON stiamo Fermi ad Aspettare! [PDF]

, 2016
Luisa Pavia Sternfeld
openalex   +1 more source